Blood cancers, Myeloma
Results
Phase 2
This trial looked at combining carfilzomib with cyclophosphamide and dexamethasone to treat myeloma.
It was open to people with myeloma that continued to grow during treatment or came back after treatment.
Recruitment start: 7 February 2013
Recruitment end: 5 September 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Kwee Yong
Leeds Institute of Clinical Trials Research (University of Leeds)
Myeloma UK
Onyx Pharmaceuticals, a subsidiary of Amgen Inc
Institute of Cancer Research (ICR)
Haematological Malignancies Diagnostic Service (HMDS)
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
UK Myeloma Research Alliance
Last reviewed: 24 Sept 2018
CRUK internal database number: 10193
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
